MIF and neoplasm: Collectively, these results demonstrate that loss or inhibition of MIF in solid tumors effectively reprograms intra-tumoral TAMs from an immunosuppressive, pro-angiogenic, tumor-promoting phenotype to an immunostimulatory, non-angiogenic, anti-tumor phenotype (79).